<div align="center">

# Prostate Cancer Translational Research Hub

[![Live Site](https://img.shields.io/badge/Live_Site-Visit_Online-blue?style=for-the-badge&logo=github-pages)](https://schoo7.github.io/pcatools/)
[![GitHub stars](https://img.shields.io/github/stars/schoo7/pcatools?style=for-the-badge&logo=github)](https://github.com/schoo7/pcatools/stargazers)
[![GitHub forks](https://img.shields.io/github/forks/schoo7/pcatools?style=for-the-badge&logo=github)](https://github.com/schoo7/pcatools/network)
[![License](https://img.shields.io/badge/License-MIT-green?style=for-the-badge)](LICENSE)

A comprehensive **GitHub Pages** site hosting an integrated suite of bioinformatics tools for prostate cancer translational research. This hub bridges **bedside**, **bench**, and **bytes** through accessible, cutting-edge computational platforms.

---

## **[Visit the Prostate Cancer Research Hub](https://schoo7.github.io/pcatools/)**

*Experience the future of cancer research tools with our modern, interactive platform*

</div>

---

# Siyuan Cheng, Ph.D.

**Postdoctoral Associate** | Department of Urology, Yale University  
[siyuan.cheng@yale.edu](mailto:siyuan.cheng@yale.edu) | [Google Scholar](https://scholar.google.com/citations?user=1D7mdDsAAAAJ&hl=en) | [ResearchGate](https://www.researchgate.net/profile/Siyuan-Cheng-2)

## Professional Service

### Editorial Roles
- **Review Editor**: *Frontiers in Oncology*

### Peer Reviewer
Active reviewer for leading oncology and biology journals, including:
- *Oncogene*
- *Molecular Cancer*
- *npj Precision Oncology*
- *Cell & Bioscience*
- *Cell Biology and Toxicology*
- *Scientific Reports*
- *Journal of Translational Medicine*
- *Journal of Cancer Research and Clinical Oncology*
- *Human Genomics*
- *Discover Oncology*

## Selected Publications

### First & Corresponding Author
1. **Cheng, S.**, Li, L., Yeh, Y., & Yu, X. (2024). Unveiling novel double-negative prostate cancer subtypes through single-cell RNA sequencing analysis. *npj Precision Oncology*, 8, 171.
2. **Cheng, S.**, Li, L., & Yu, X. (2024). PCTA, a pan-cancer cell line transcriptome atlas. *Cancer Letters*, 586, 216808.
3. Li, L., Cho, K. H., Yu, X., & **Cheng, S.** (2025). Systematic multi-omics investigation of androgen receptor driven gene expression and epigenetics changes in prostate cancer. *Computers in Biology and Medicine*, 189, 110000. (**Corresponding Author**)
4. **Cheng, S.**, & Yu, X. (2023). CTPC, a combined transcriptome data set of human prostate cancer cell lines. *The Prostate*, 83(2), 158-161. (**Cover Image**)
5. **Cheng, S.**, Yang, S., Shi, Y., Shi, R., Yeh, Y., & Yu, X. (2021). Neuroendocrine prostate cancer has distinctive, non-prostatic HOX code that is represented by the loss of HOXB13 expression. *Scientific Reports*, 11(1), 2778. (**Top 100 in Cancer Collection**)
6. **Cheng, S.**, & Yu, X. (2021). The spectrum of neuroendocrine differentiation in prostate cancer. *Prostate Cancer and Prostatic Diseases*, 24(4), 1214-1215.
7. **Cheng, S.**, Prieto-Dominguez, N., et al. (2020). The Expression of YAP1 Is Increased in High-Grade Prostatic Adenocarcinoma but Is Reduced in Neuroendocrine Prostate Cancer. *Prostate Cancer and Prostatic Diseases*, 23(4), 661-669.

*For a comprehensive list of publications, please visit my [Google Scholar profile](https://scholar.google.com/citations?user=1D7mdDsAAAAJ&hl=en).*

## Education
- **Postdoctoral Training** (Prostate Cancer), Yale University (2025–Present)
- **Postdoctoral Training** (Prostate Cancer), LSU Health Shreveport (2022–2024)
- **Ph.D. Biochemistry & Molecular Biology**, LSU Health Shreveport (2018–2022)
- **B.S. Biotechnology**, Hunan University (2013–2017)

## Developed Bioinformatics Resources
- **[CTPC](https://pcatools.shinyapps.io/CTPC_dev/):** Combined Transcriptome of Prostate Cancer Cell Lines (1,840 samples).
- **[HuPSA-MoPSA](https://pcatools.shinyapps.io/HuPSA-MoPSA/):** Single-cell atlas explorer for human & mouse prostate.
- **[PCTA](https://pcatools.shinyapps.io/PCTA_app/):** Pan-Cancer Cell Line Transcriptome Atlas (84,000+ samples).
- **[LNCaP-ADT](https://pcatools.shinyapps.io/shinyADT/):** Multi-omics hub for Androgen Deprivation Therapy resistance.